Department of Health and Human Services National Institutes of Health Recombinant DNA Advisory Committee: minutes of meeting, September 25-26, 2000.
D000260:Adenoviruses, Human / Q000235:genetics; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use; D002985:Clinical Protocols; D004274:DNA, Recombinant / Q000009:adverse effects / Q000627:therapeutic use*; D018014:Gene Transfer Techniques / Q000009:adverse effects / Q000592:standards; D005814:Genes, Viral; D015497:HIV-1 / Q000235:genetics; D006801:Humans; D009316:National Institutes of Health (U.S.); D014481:United States
D019380:Anti-HIV Agents; D004274:DNA, Recombinant